Table 1 Summary of cases reported in literature of vision loss in GBS due to Angle closure glaucoma
From: Acute vision loss in Guillain–Barré syndrome: A case series and review of literature
Baxter JM et al. [5] | Han J et al. [7] | Ryu, W. Y. et al. [6] | Brittain CJ et al. [4] | Our case | |
|---|---|---|---|---|---|
Variant of GBS | MFS | MFS | MFS | MFS | AIDP |
Age (years)/sex | 55/male | 78/female | 75/male | 64/male | 45/female |
Onset of vision loss | Presenting complaint | Presenting complaint | Presenting complaint | Presenting complaints | During recovery |
Laterality of symptoms | Bilateral | Unilateral (left eye) | Unilateral (Right Eye) | Unilateral (left eye) | Bilateral |
IOP at onset (RE and LE) | 56 mm of Hg 48 mm of Hg | 18 mm of Hg 48 mm of Hg | 50 mm of Hg 18 mm of Hg | 20 mm of Hg 56 mm of Hg | 52 mm of Hg 48 mm of Hg |
BCVA at onset (RE and LE) | HM 6/18 | 0.6 PL | RE- HM | 6/9 HM | RE-3/60 LE-6/60 |
ACD | Absent | Present | Present | Not Mentioned | Present |
CSF Proteins | Not given | 526 mg/dl | 53 mg/dl | Not given | 156.6 mg/dl |
Medical treatment | Acetazolamide Topical pilocarpine, timolol and iopidine | Mannitol Topical timolol and pilocarpine | Mannitol Topical Latanaprost, Brinzolamide and Timolol | Acetazolamide Topical Timolol, Latanaprost, Iopidine | Mannitol, Acetazolamide Topical timolol |
Surgical treatment | Laser peripheral iridotomy | None | Laser peripheral iridotomy | Laser peripheral iridotomy | Laser peripheral iridotomy |
IVIg therapy | Given | Given | Given | Given | Given |
IOP after treatment (RE and LE) | 23 mm of Hg 12 mm of Hg | 18 mm of Hg 20 mm of Hg | 11 mm of Hg 18 mm of Hg | 13 mm of Hg 6 mm of Hg | 19 mm of Hg 16 mm of Hg |
Time of Reassessment after starting of treatment | 6 months | 2 days | 2 days | 2 days | 2 months |
BCVA after treatment (RE and LE) | RE-6/6 LE-6/6 | RE-0.8 LE-0.6 | RE-10/20 | RE-6/6 LE-6/6 | RE-6/18 LE-6/12 |